| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | EVP, COO, Head of Commercial | EVP, COO, Head of Commercial
2 companies
Brendan Teehan is Chief Commercial Officer at PCRX, with reported holdings spanning 2 companies. From January 2022 to February 2026, the filings on record show 0 open-market purchases and 16 sales. Brendan Teehan's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5.0M at current prices.
Our model assigns Brendan Teehan a middling insider score of 62/100, based on 16 past trades. Over a 12-month horizon, 68.8% of those trades were profitable, with an average 12-month return of +1.4%.
Brendan Teehan's largest disclosed position is in PCRX as Chief Commercial Officer, worth about $3.7M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, COO, Head of Commercial | Sale+OE | 1,751 | $18.16 | $31,798.16 | -17.1% | +31.7% | -1.9% | |
| Feb 24, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, COO, Head of Commercial | Sale+OE | 461 | $18.78 | $8,657.58 | -8.2% | +29.2% | +31.0% | |
| Jan 9, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, COO, Head of Commercial | Sale+OE | 532 | $17.13 | $9,113.32 | -10.5% | +5.6% | +81.9% | |
| May 2, 2022 | ACAD Acadia Pharmaceuticals Inc | EVP, COO, Head of Commercial | Sale+OE | 552 | $18.18 | $10,036.46 | -13.8% | -27.8% | +9.4% | |
| Feb 23, 2022 | ACAD Acadia Pharmaceuticals Inc | EVP, COO, Head of Commercial | Sale+OE | 472 | $23.80 | $11,233.60 | -16.3% | -35.3% | -22.6% | |
| Jan 6, 2022 | ACAD Acadia Pharmaceuticals Inc | EVP, COO, Head of Commercial | Sale+OE | 538 | $23.05 | $12,400.90 | -23.1% | +16.4% | -26.0% |